Prognostic Impact of In-Hospital and Postdischarge Heart Failure in Patients With Acute Myocardial Infarction: A Nationwide Analysis Using Data From the Cardiovascular Disease in Norway (CVDNOR) Project
Author(s)
Type
Journal Article
Abstract
Background-—Heart failure (HF) is a serious complication of acute myocardial infarction (AMI). We explored the excess mortality
associated with HF as an early or late complication of AMI and describe changes over time in such excess mortality.
Methods and Results-—All patients hospitalized with an incident AMI and without history of prior HF hospitalization were followed
up to 1 year after AMI discharge for episodes of HF. New HF episodes were classified as in-hospital HF if diagnosed during the AMI
hospitalization or postdischarge HF if diagnosed within 1 year after discharge from the incident AMI. Logistic and Cox regression
models were used to explore the excess mortality associated with HF categories. Changes over time in the excess mortality were
assessed by testing the interaction between HF status and study year. In-hospital HF increased in-hospital mortality 1.79 times
(odds ratio [OR], 1.79; 95% CI: 1.68–1.91). The excess mortality associated with HF increased by 4.3 times from 2001 to 2009
(P interaction<0.001) as a consequence of a greater decline of in-hospital mortality among AMI patients without (9% per year)
compared to those with in-hospital HF (3% per year). Postdischarge HF increased all-cause and CVD mortality 5.98 times (hazard
ratio, 5.98; 95% CI: 5.39–6.64) and 7.93 times (subhazard ratio, 7.93; 95% CI: 6.84 –9.19), respectively. The relative excess 1-year
mortality associated with HF did not change significantly over time.
Conclusions-—Development of HF—either as an early or late complication of AMI—has a negative impact on patients’ survival.
Changes in the excess mortality associated with HF are driven by modest improvements in survival among AMI patients with HF as
compared to those without HF.
associated with HF as an early or late complication of AMI and describe changes over time in such excess mortality.
Methods and Results-—All patients hospitalized with an incident AMI and without history of prior HF hospitalization were followed
up to 1 year after AMI discharge for episodes of HF. New HF episodes were classified as in-hospital HF if diagnosed during the AMI
hospitalization or postdischarge HF if diagnosed within 1 year after discharge from the incident AMI. Logistic and Cox regression
models were used to explore the excess mortality associated with HF categories. Changes over time in the excess mortality were
assessed by testing the interaction between HF status and study year. In-hospital HF increased in-hospital mortality 1.79 times
(odds ratio [OR], 1.79; 95% CI: 1.68–1.91). The excess mortality associated with HF increased by 4.3 times from 2001 to 2009
(P interaction<0.001) as a consequence of a greater decline of in-hospital mortality among AMI patients without (9% per year)
compared to those with in-hospital HF (3% per year). Postdischarge HF increased all-cause and CVD mortality 5.98 times (hazard
ratio, 5.98; 95% CI: 5.39–6.64) and 7.93 times (subhazard ratio, 7.93; 95% CI: 6.84 –9.19), respectively. The relative excess 1-year
mortality associated with HF did not change significantly over time.
Conclusions-—Development of HF—either as an early or late complication of AMI—has a negative impact on patients’ survival.
Changes in the excess mortality associated with HF are driven by modest improvements in survival among AMI patients with HF as
compared to those without HF.
Date Issued
2017-03-01
Date Acceptance
2017-02-09
Citation
Journal of the American Heart Association, 2017, 6 (3)
ISSN
2047-9980
Publisher
Wiley
Journal / Book Title
Journal of the American Heart Association
Volume
6
Issue
3
Copyright Statement
ª 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is
non-commercial and no modifications or adaptations are made.
Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is
non-commercial and no modifications or adaptations are made.
Subjects
Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
acute myocardial infarction
CVDNOR
heart failure
mortality
Norway
trends
ACUTE CORONARY SYNDROMES
REGISTRY
TRENDS
POPULATION
RATES
PERSPECTIVE
DYSFUNCTION
PREDICTORS
MORTALITY
OUTCOMES
Publication Status
Published
Article Number
e005277